CD4 and tuberculosis: A meta-analysis of all eleven studies meeting inclusion criteria found that antiretroviral therapy is strongly associated with a reduction in tuberculosis incidence across all baseline CD4 counts (HR 0.35, 95% confidence interval [CI] 0.28 to 0.44; p-value for effect <0.001; p-value for heterogeneity = 0.151).